Personalized Testing Options

to fit your every need

Cornerstone Diagnostics offers a vast array of testing options, all at clinically relevant cut-offs to arm you with the information you need to make adequate prescribing decisions.

Confirmation Panels

Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.

Our test catalog allows you to choose the most relevant testing options that best meet the specific needs of each patient.

Test Catalog
  • 114 - Comprehensive
  • 115 - Basic
  • 116 - Behavorial Health
  • 117 - Pain Management
  • 118 - Long-Term Monitoring

Qualitative Analysis

Cornerstone Diagnostics qualitative testing utilizes leading edge sensitivity for the identification of targeted drugs and drug classes. Cornerstone Diagnostics qualitative analysis provides clinically relevant drug detection for enhanced compliance monitoring and improved patient outcomes.

Our test catalog allows you to choose the most relevant testing options that best meet the specific needs of each patient.

Test Catalog
  • 103 - UPT - Urine Pregnancy Test
  • 128 - ScreenZT
  • 129 - 12 Panel Drug Screen
  • 136 - 11 Panel Drug Screen

Reflex Analysis

Managing your patients' compliance with prescribed treatment is complex. Effective monitoring requires testing that's flexible to the individual needs of the patient, while precisely detecting Cornerstone Diagnostics AutoReflex, is a recommended methodology for medically necessary compliance monitoring by most insurance companies, including Medicare.

Our test catalog allows you to choose the most relevant testing options that best meet the specific needs of each patient.

Test Catalog
  • 8128 - AutoReflexZT
  • 8129 - 12 AutoReflex
  • 8136 - 11 AutoReflex

501 - Oral Fluid Quantitative Assay

The Corner Stone Diagnostics Oral Fluid Quantitative Assay is a highly sophisticated test for drugs and metabolites in saliva. Our proprietary analytical methodology employs some of the most sensitive detection cut-offs in the industry to support your therapeutic drug monitoring needs when urine testing is not an available option.

Our test catalog allows you to choose the most relevant testing options that best meet the specific needs of each patient.

Test Catalog
  • 501 - Oral Fluid Quantitative Assay

Quantitative Analysis

Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.

Our test catalog allows you to choose the most relevant testing options that best meet the specific needs of each patient.

Test Catalog
  • 104 - ETG (Alcohol Metabolite)
  • 106 - Methylphenidate Group
  • 107 - Amphetamine Group
  • 108 - Barbiturate Group
  • 109 - Benzodiadepine-Sedative Group
  • 110 - Buprenorphine Group
  • 111 - THC (marijuana)
  • 112 - Benzoylecgonine (Cocaine Metabolite)
  • 113 - Opioid Group
  • 119 - Illicit Group
  • 121 - Tapentadol Group
  • 122 - Gabapentin
  • 123 - Pregabalin
  • 124 - Carisoprodol Group
  • 125 - PCP
  • 126 - Ecstacy Group
  • 132 - Propoxyphene
  • 133 - Meperidine Group
  • 137 - Naloxone Group
  • 138 - Antidepressant Group
  • 139- Levorphanol
  • 155 - Synthetic Cannabinoids
  • 156 - Expanded Synthetic Cathinones
  • 162 - Mitragynine
  • 163 - Barbiturate Sub Group
  • 165 - Phentermine
  • 167 - Nicotine Group
  • 171 - Oxycodone Group
  • 172 - Fentanyl Group
  • 173 - Methadone Group
  • 174 - Naltrexone Group
  • 175 - 6-Acetylmorphine (Heroin Metabolite)
  • 176 - Tramadol Group
  • 177 - Alprazolam Group
  • 178 - Diazepam Group
  • 179 - 7-Aminoclonazepam
  • 180 - Lorazepam
  • 369 - Opiates Group
  • 370 - Benzodiazepine Select Group
  • ISOM - Methamphetamine d&l Isomer Testing